DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05
Published December 2, 2020 · Recall initiated: November 17, 2020
Summary
FDA records drug Class III recall D-0105-2021, published December 2, 2020 and initiated November 17, 2020. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 16,986 vials; Lot: Batch: 6120525, exp 11/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products: trace amounts of octreotide found during testing
What to do
Voluntary: Firm initiated · Letter
Get an email if DOXORUBICIN HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DOXORUBICIN HYDROCHLORIDE
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide USA and Puerto Rico
- Lot
- Batch: 6120525, exp 11/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only,June 17, 2026
- FDAclomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant CadistaDecember 2, 2020
- FDAImmune Boost with natural strawberry flavor, 8,000 IU, Supports a Healthy and Balanced Immune System, 60 mLDecember 2, 2020
- FDAParoex (chlorhexidine gluconate) Oral Rinse, USP 0.12%, Alcohol Free, Rx only, packaged in: a) 1 pint (473 mL)December 2, 2020
- FDAFelodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: HeritageDecember 2, 2020
- FDASYP Health Hand Sanitizer Alcohol Gel (ethyl alcohol) 70%, Net Wt. 16.91 FL OZ (500 mL) bottles,Biotecnologia,December 2, 2020
Questions about this recall
Was DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05 recalled?
Yes. FDA published recall D-0105-2021 on December 2, 2020. Reported hazard: Cross Contamination with Other Products: trace amounts of octreotide found during testing
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DOXORUBICIN HYDROCHLORIDE.